Literature DB >> 8319658

Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment.

F A Beland1, M C Poirier.   

Abstract

To elucidate the relationship between DNA adduct formation and tumorigenesis, a number of experiments have been conducted to measure DNA adducts in target tissues from experimental animals during continuous exposure to carcinogens. With aflatoxins, aromatic amines, and polycyclic aromatic hydrocarbons, tumor induction appears to be associated with the major DNA adduct detected, whereas with N-nitrosamines the response is normally correlated with minor forms of DNA damage. During continuous carcinogen administration, steady-state adduct concentrations are generally obtained in the target tissues, and there is often a linear correlation between the carcinogen concentration and the steady-state DNA adduct level. Exceptions exist when the mechanism of activation changes or with the onset of significant toxicity. Steady-state DNA adduct levels are often linearly related to the tumorigenic response. Carcinogen-induced cell proliferation occurs when significant deviations from linearity are observed. Because DNA adducts detected in humans are chemically identical to those found in experimental animals, DNA adduct data in animals may contribute to our understanding of human cancer risk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319658      PMCID: PMC1567051          DOI: 10.1289/ehp.93995

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  50 in total

1.  Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.

Authors:  J M Essigmann; R G Croy; A M Nadzan; W F Busby; V N Reinhold; G Büchi; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  Gastric tumors in mice fed benzo(a)pyrene: a quantitative study.

Authors:  J Neal; R H Rigdon
Journal:  Tex Rep Biol Med       Date:  1967

3.  A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays.

Authors:  F P Perera; M C Poirier; S H Yuspa; J Nakayama; A Jaretzki; M M Curnen; D M Knowles; I B Weinstein
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

4.  Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7'-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya.

Authors:  H Autrup; K A Bradley; A K Shamsuddin; J Wakhisi; A Wasunna
Journal:  Carcinogenesis       Date:  1983-09       Impact factor: 4.944

5.  Characterisation of the imidazole ring-opened forms of trans-8,9-dihydro-8,9-dihydro-8-(7-guanyl)9-hydroxy aflatoxin B1.

Authors:  P J Hertzog; J R Smith; R C Garner
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

6.  Alkylation of deoxyribonucleic acid in vivo in various organs of C57BL mice by the carcinogens N-methyl-N-nitrosourea, N-ethyl-N-nitrosourea and ethyl methanesulphonate in relation to induction of thymic lymphoma. Some applications of high-pressure liquid chromatography.

Authors:  J V Frei; D H Swenson; W Warren; P D Lawley
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

7.  Fluorescence detection of benzo[a]pyrene--DNA adducts in human lung.

Authors:  A Weston; E D Bowman
Journal:  Carcinogenesis       Date:  1991-08       Impact factor: 4.944

8.  Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning.

Authors:  D C Herron; R C Shank
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

9.  Tissue binding of 2-acetylaminofluorene in BAlB/c and C57Bl/6 mice during chronic oral administration.

Authors:  C D Jackson; C Weis; T E Shellenberger
Journal:  Chem Biol Interact       Date:  1980-10       Impact factor: 5.192

10.  Tobacco as a risk factor in bladder cancer.

Authors:  S Mommsen; J Aagaard
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

View more
  7 in total

1.  Correlation of individual papilloma latency time with DNA adducts, 8-hydroxy-2'-deoxyguanosine, and the rate of DNA synthesis in the epidermis of mice treated with 7,12-dimethylbenz[alpha]anthracene.

Authors:  W H Fischer; W K Lutz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

2.  Biomarkers of individual susceptibility to carcinogens: application for biological monitoring.

Authors:  A J Likhachev; D Sh Beniashvili; V J Bykov; O I Kazanova; N A Loktionova; M L Tyndyk; O S Yatsuk; V B Yermilov; M A Zabezhinski
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

3.  Evaluation of biomarkers in plasma, blood, and urine samples from coke oven workers: significance of exposure to polycyclic aromatic hydrocarbons.

Authors:  S Ovrebø; A Haugen; P B Farmer; D Anderson
Journal:  Occup Environ Med       Date:  1995-11       Impact factor: 4.402

4.  Formation and repair of tobacco carcinogen-derived bulky DNA adducts.

Authors:  Bo Hang
Journal:  J Nucleic Acids       Date:  2010-12-20

Review 5.  Fish models for environmental carcinogenesis: the rainbow trout.

Authors:  G S Bailey; D E Williams; J D Hendricks
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

6.  Polycyclic Aromatic Hydrocarbon-DNA Adducts in Gulf of Mexico Sperm Whale Skin Biopsies Collected in 2012.

Authors:  Miriam C Poirier; Letizia Marsili; Maria Cristina Fossi; Céline A J Godard-Codding; Elena E Hernandez-Ramon; Nancy Si; Kathyayini V Divi; Rao L Divi; Iain Kerr; John Pierce Wise; Catherine F Wise; Sandra S Wise; Abou El-Makarim Aboueissa; James T F Wise; John Pierce Wise
Journal:  Toxicol Sci       Date:  2021-04-27       Impact factor: 4.849

7.  Formation of DNA adducts and induction of mutations in rats treated with tumorigenic doses of 1,6-dinitropyrene.

Authors:  F A Beland; N F Fullerton; B A Smith; R H Heflich
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.